Merck & Co Inc
XETRA:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XETRA:6MK
|
US |
|
S
|
Sabre Resources Ltd
F:SAL
|
AU |
|
B
|
BXP Inc
F:BO9
|
US |
|
I
|
IP Strategy Holdings Inc
NASDAQ:IPST
|
US |
|
Growthpoint Properties Ltd
F:G5JA
|
ZA |
|
L
|
Land Securities Group PLC
F:LSU2
|
UK |
|
WisdomTree Inc
F:1WT
|
US |
|
G
|
Grindrod Ltd
JSE:GND
|
ZA |
|
C
|
Copart Inc
F:CO6
|
US |
|
F
|
Ferrari NV
SWB:2FE
|
IT |
Intrinsic Value
Is 6MK undervalued or overvalued?
See the intrinsic value estimate for 
Merck & Co Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Merck Does
Merck & Co. is a global drug company that makes prescription medicines, vaccines, and animal health products. Its best-known business is developing and selling branded drugs for cancer, infectious disease, diabetes, and other serious conditions. It also sells vaccines and medicines used by veterinarians and livestock producers.
- Headquarters
- United States of America US
- Employees
- 75 000
- IPO date
- Jan 1, 1941
Merck & has a wide economic moat
Legal protection for Merck’s medicines prevents rivals from freely selling copies, allowing it to earn more than it could in a market filled with cheaper alternatives. Its protected treatments span cancer, vaccines and other diseases, so this protection extends beyond a single medicine.
Read the full moat analysis
Revenue & Expenses Breakdown
Merck & Co Inc
Earnings Waterfall
Merck & Co Inc
The intrinsic value for Merck & Co Inc (6MK) under the Base Case is hidden EUR.
Compared with the current market price of 131.86 EUR, the stock appears hidden.
